Phreesia's Revenue Jumps 18% to $92.4M, Net Loss Widens to $30.1M
Ticker: PHR · Form: 10-Q · Filed: May 28, 2025 · CIK: 1412408
| Field | Detail |
|---|---|
| Company | Phreesia, INC. (PHR) |
| Form Type | 10-Q |
| Filed Date | May 28, 2025 |
| Risk Level | medium |
| Sentiment | mixed |
Sentiment: mixed
Topics: Healthcare Technology, SaaS, Revenue Growth, Net Loss, Patient Engagement, Q1 Earnings, Unprofitable Growth
Related Tickers: PHR
TL;DR
Phreesia is growing revenue fast but still bleeding cash, so don't expect profits anytime soon.
AI Summary
Phreesia, Inc. reported total revenue of $92.4 million for the three months ended April 30, 2025, a significant increase from $78.1 million in the prior-year period. The company's net loss widened to $30.1 million for the quarter, compared to a net loss of $27.9 million in the same period last year. Subscription and Services revenue grew to $67.2 million from $59.0 million, while Payment Processing Fees increased to $18.5 million from $14.1 million. Network Solutions revenue also saw growth, reaching $6.7 million compared to $5.0 million. The company's accumulated deficit increased to $731.3 million as of April 30, 2025, from $701.2 million as of January 31, 2025, indicating continued unprofitability. Total operating expenses were not explicitly detailed but contributed to the increased net loss. Phreesia continues to invest in its platform, as evidenced by the growth across all revenue segments, but faces challenges in achieving profitability.
Why It Matters
Phreesia's continued revenue growth, particularly in Payment Processing Fees and Network Solutions, signals strong adoption of its healthcare technology platform, which is crucial in a competitive market. However, the widening net loss to $30.1 million raises concerns about the company's path to profitability and operational efficiency, impacting investor confidence. For employees, sustained growth could mean job security and expansion, while customers benefit from an evolving platform. The broader market watches Phreesia as a bellwether for health-tech innovation and its ability to monetize digital patient engagement solutions.
Risk Assessment
Risk Level: medium — Phreesia's net loss widened to $30.1 million for the quarter ended April 30, 2025, from $27.9 million in the prior-year period, and its accumulated deficit reached $731.3 million. This sustained unprofitability, despite revenue growth, indicates ongoing financial risk and a challenge in achieving positive cash flow from operations.
Analyst Insight
Investors should monitor Phreesia's next few quarters closely for signs of narrowing losses and improved operational efficiency. While revenue growth is positive, the widening net loss suggests that current investments are not yet translating into profitability, warranting a cautious approach.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $92.4M
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- -$30.1M
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- +18.3%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Subscription and Services | $67.2M | +13.9% |
| Payment Processing Fees | $18.5M | +31.2% |
| Network Solutions | $6.7M | +34.0% |
Key Numbers
- $92.4M — Total Revenue (Increased from $78.1M in Q1 2024, showing 18.3% growth.)
- -$30.1M — Net Loss (Widened from -$27.9M in Q1 2024, indicating increased unprofitability.)
- $67.2M — Subscription and Services Revenue (Grew from $59.0M in Q1 2024, a 13.9% increase.)
- $18.5M — Payment Processing Fees (Increased from $14.1M in Q1 2024, a 31.2% increase.)
- $6.7M — Network Solutions Revenue (Rose from $5.0M in Q1 2024, a 34.0% increase.)
- $731.3M — Accumulated Deficit (Increased from $701.2M as of January 31, 2025, reflecting ongoing losses.)
Key Players & Entities
- Phreesia, Inc. (company) — filer of the 10-Q
- $92.4 million (dollar_amount) — total revenue for Q1 2025
- $78.1 million (dollar_amount) — total revenue for Q1 2024
- $30.1 million (dollar_amount) — net loss for Q1 2025
- $27.9 million (dollar_amount) — net loss for Q1 2024
- $67.2 million (dollar_amount) — Subscription and Services revenue for Q1 2025
- $59.0 million (dollar_amount) — Subscription and Services revenue for Q1 2024
- $18.5 million (dollar_amount) — Payment Processing Fees revenue for Q1 2025
- $14.1 million (dollar_amount) — Payment Processing Fees revenue for Q1 2024
- $731.3 million (dollar_amount) — accumulated deficit as of April 30, 2025
FAQ
What were Phreesia's total revenues for the quarter ended April 30, 2025?
Phreesia, Inc. reported total revenues of $92.4 million for the three months ended April 30, 2025, an increase from $78.1 million in the prior-year period.
Did Phreesia, Inc. achieve profitability in the first quarter of 2025?
No, Phreesia, Inc. did not achieve profitability, reporting a net loss of $30.1 million for the three months ended April 30, 2025, which widened from a net loss of $27.9 million in the same period last year.
How much did Phreesia's Subscription and Services revenue contribute to total revenue?
Subscription and Services revenue contributed $67.2 million to Phreesia's total revenue for the quarter ended April 30, 2025, up from $59.0 million in the prior-year period.
What was the change in Phreesia's Payment Processing Fees revenue?
Phreesia's Payment Processing Fees revenue increased to $18.5 million for the three months ended April 30, 2025, compared to $14.1 million in the same period last year.
What is Phreesia's accumulated deficit as of April 30, 2025?
As of April 30, 2025, Phreesia's accumulated deficit stood at $731.3 million, an increase from $701.2 million as of January 31, 2025.
How did Phreesia's Network Solutions revenue perform in Q1 2025?
Phreesia's Network Solutions revenue grew to $6.7 million for the quarter ended April 30, 2025, an increase from $5.0 million in the comparable prior-year period.
What are the key risks for Phreesia investors based on this 10-Q?
A key risk for Phreesia investors is the company's widening net loss of $30.1 million and growing accumulated deficit of $731.3 million, indicating continued unprofitability despite revenue growth.
What is the primary business of Phreesia, Inc.?
Phreesia, Inc. provides a patient intake and engagement platform for the healthcare industry, generating revenue primarily from subscriptions, payment processing fees, and network solutions.
When was Phreesia's 10-Q filing for the quarter ended April 30, 2025, submitted?
Phreesia's 10-Q filing for the quarter ended April 30, 2025, was filed with the SEC on May 28, 2025.
How does Phreesia's revenue growth compare year-over-year?
Phreesia's total revenue grew from $78.1 million in the three months ended April 30, 2024, to $92.4 million in the same period of 2025, representing an 18.3% year-over-year increase.
Industry Context
Phreesia operates in the healthcare technology sector, specifically focusing on patient intake and engagement solutions. The industry is characterized by increasing adoption of digital health tools, a need for improved patient experience, and a focus on revenue cycle management for healthcare providers. Competition includes other patient engagement platforms and electronic health record (EHR) vendors offering similar functionalities.
Regulatory Implications
As a healthcare technology company, Phreesia must comply with stringent data privacy regulations such as HIPAA. Any breaches or non-compliance could lead to significant fines and reputational damage. Changes in healthcare reimbursement policies could also impact provider adoption of new technologies.
What Investors Should Do
- Monitor path to profitability
- Assess growth drivers
- Evaluate competitive positioning
Glossary
- Accumulated Deficit
- The cumulative net losses of a company that have not been offset by net income in subsequent periods. (Indicates Phreesia's ongoing unprofitability, with the deficit increasing to $731.3 million as of April 30, 2025.)
- Subscription and Services Revenue
- Revenue generated from recurring fees for access to Phreesia's software platform and related services. (Represents the largest segment of Phreesia's revenue, growing to $67.2 million, showing the strength of its core business model.)
- Payment Processing Fees
- Revenue earned from facilitating patient payments through the Phreesia platform. (This segment showed the highest percentage growth at 31.2%, reaching $18.5 million, suggesting increased transaction volume and adoption.)
- Network Solutions Revenue
- Revenue derived from services and solutions offered through Phreesia's healthcare network. (This segment experienced strong growth of 34.0% to $6.7 million, indicating successful expansion of its network offerings.)
Year-Over-Year Comparison
Compared to the prior-year period, Phreesia reported an 18.3% increase in total revenue, reaching $92.4 million. However, the net loss also widened to $30.1 million from $27.9 million, indicating a decrease in profitability. Key revenue segments like Payment Processing Fees and Network Solutions showed robust growth rates of 31.2% and 34.0% respectively, while Subscription and Services revenue grew by 13.9%. The accumulated deficit continued to increase, underscoring the ongoing investment and challenge in achieving profitability.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 28, 2025 regarding Phreesia, Inc. (PHR).